Changes in [18F]Fluorothymidine Pharmacokinetics Following Capecitabine Treatment in Human Breast Cancer Detected by Positron Emission Tomography

被引：0
|
作者：
Kenny, L. M.
Contractor, K.
Stebbing, J.
Al-Nahhas, A.
Palmieri, C.
Shousha, S.
Aboagye, E. O.
Coombes, R. C.
机构：
[1] Univ London Imperial Coll Sci Technol & Med, London, England
[2] Imperial Coll NHS Healthcare Trust, London, England
来源：
CANCER RESEARCH | 2009年 / 69卷 / 24期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：765S / 765S
页数：1
相关论文
共 50 条
  • [31] Positron emission tomography with [18F]-FDG in oncology
    Talbot, JN
    Petegnief, Y
    Kerrou, K
    Montravers, F
    Grahek, D
    Younsi, N
    NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION A-ACCELERATORS SPECTROMETERS DETECTORS AND ASSOCIATED EQUIPMENT, 2003, 504 (1-3): : 129 - 138
  • [32] The role of [18F]-fluorothymidine positron emission tomography (FLT-PET) in the diagnosis of [18F]-fluorodeoxyglucose (FDG) avid lung lesions.
    Giraudet, A.
    Beauregard, J.
    Roselt, P.
    Hicks, R. J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 : S166 - S166
  • [33] Study of Synthesis of 3′-Deoxy-3′-[18F]fluorothymidine - Prospective Radiopharmaceutical in Positron Emission Tomography
    Prochazka, Libor
    Kropacek, Martin
    Mirzajevova, Marcela
    Zimova, Jana
    Foersterova, Michaela
    Svecova, Helena
    Melichar, Frantisek
    CHEMICKE LISTY, 2008, 102 (11): : 992 - 996
  • [34] Early Prediction of Nonprogression in Advanced Non-Small-Cell Lung Cancer Treated With Erlotinib By Using [18F]Fluorodeoxyglucose and [18F]Fluorothymidine Positron Emission Tomography
    Zander, Thomas
    Scheffler, Matthias
    Nogova, Lucia
    Kobe, Carsten
    Engel-Riedel, Walburga
    Hellmich, Martin
    Papachristou, Irini
    Toepelt, Karin
    Draube, Andreas
    Heukamp, Lukas
    Buettner, Reinhard
    Ko, Yon D.
    Ullrich, Roland T.
    Smit, Egbert
    Boellaard, Ronald
    Lammertsma, Adriaan A.
    Hallek, Michael
    Jacobs, Andreas H.
    Schlesinger, Andreas
    Schulte, Karin
    Querings, Silvia
    Stoelben, Erich
    Neumaier, Bernd
    Thomas, Roman K.
    Dietlein, Markus
    Wolf, Juergen
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (13) : 1701 - 1708
  • [35] Radionuclide impurities in [18F]F- and [18F]FDG for positron emission tomography
    Koehler, M.
    Degering, D.
    Zessin, J.
    Fuechtner, F.
    Konheiser, J.
    APPLIED RADIATION AND ISOTOPES, 2013, 81 : 268 - 271
  • [36] Imaging early changes in proliferation at 1 week post chemotherapy:: a pilot study in breast cancer patients with 3′-deoxy-3′-[18F]fluorothymidine positron emission tomography
    Kenny, Laura
    Coombes, R. Charles
    Vigushin, David M.
    Al-Nahhas, Adil
    Shousha, Sami
    Aboagye, Eric O.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 (09) : 1339 - 1347
  • [37] Changes in 18F-fluorothymidine and 18F-fluorodeoxyglucose positron emission tomography imaging in patients with head and neck cancer treated with chemoradiotherapy
    Hoshikawa, Hiroshi
    Mori, Terushige
    Kishino, Takehito
    Yamamoto, Yuka
    Inamoto, Ryuhei
    Akiyama, Kosuke
    Mori, Nozomu
    Nishiyama, Yoshihiro
    ANNALS OF NUCLEAR MEDICINE, 2013, 27 (04) : 363 - 370
  • [38] Potential impact of [18F]3′-deoxy-3′-fluorothymidine versus [18F]fluoro-2-deoxy--glucose in positron emission tomography for colorectal cancer
    Francis, DL
    Visvikis, D
    Costa, DC
    Arulampalam, THA
    Townsend, C
    Luthra, SK
    Taylor, I
    Ell, PJ
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2003, 30 (07) : 988 - 994
  • [39] Changes in 18F-fluorothymidine and 18F-fluorodeoxyglucose positron emission tomography imaging in patients with head and neck cancer treated with chemoradiotherapy
    Hiroshi Hoshikawa
    Terushige Mori
    Takehito Kishino
    Yuka Yamamoto
    Ryuhei Inamoto
    Kosuke Akiyama
    Nozomu Mori
    Yoshihiro Nishiyama
    Annals of Nuclear Medicine, 2013, 27 : 363 - 370
  • [40] Imaging early changes in proliferation at 1 week post chemotherapy: a pilot study in breast cancer patients with 3′-deoxy-3′-[18F]fluorothymidine positron emission tomography
    Laura Kenny
    R. Charles Coombes
    David M. Vigushin
    Adil Al-Nahhas
    Sami Shousha
    Eric O. Aboagye
    European Journal of Nuclear Medicine and Molecular Imaging, 2007, 34 : 1339 - 1347
12345